Background: Luteal phase deficiency (LPD) was recognized as a potential cause of infertility well before the first
Introduction
Luteal phase deficiency (LPD), characterized by insufficient secretion of progesterone by the corpus luteum, was first studied and treated by Georgeanna Seegar Jones in the 1940s [1, 2] , well before the beginning of the assisted reproduction era. It is known to be associated with ovarian stimulation protocols for in vitro fertilization (IVF), in general, and particularly with protocols that utilize a gonadotropin releasing hormone (GnRH) agonist as trigger [3, 4] . On the other hand, it is currently considered to be a relatively infrequent cause of infertility in natural ovulatory cycles [5] .
Midluteal phase serum progesterone level is currently the most widely used as a diagnostic tool for LPD. In spite of the pulsatile character of progesterone release from the corpus luteum, reflecting the pulsatile release of LH from the pituitary [6] , a single serum progesterone level below 10 ng/ml, measured in the midluteal phase, is considered as a reliable indicator of LPD [7] .
Evaluation of midluteal serum progesterone concentration is part of the standard evaluation of infertile couples before their inclusion in our assisted reproduction program. Here we report a series of 12 cases of unexplained infertility in which LPD appeared to be the main cause. The women were monitored for spontaneous ovulation detection in three consecutive cycles and counselled to have frequent sexual intercourse around the time of ovulation. Following ovulation their luteal phase was supported with exogenous progesterone administration in an attempt to achieve and maintain a natural pregnancy.
Patients and Methods
This retrospective study involved 12 women with a duration of infertility of between 2 and 3 years, attending our clinic for an assisted reproduction attempt in the period between September 2016 and December 2018. Their age ranged from 24 to 35 years, and all of them had a normal body mass index (20.1-24.7 kg/m 2 ), regular, normal-length (27-30 days) menstrual cycles and duration of infertility between 2 and 3 years (Table  1) . Their ovarian reserve (Table 1) , as judged by antral follicle count (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) and serum levels of anti-Müllerian hormone (2.9-5.0), was normal or slightly supranormal, according to the current criteria of ovarian reserve testing [8] . All of them had normal uterine cavity, as assessed by virtual sonographic hysteroscopy [9] and none showed signs of endometriosis. Apart from the history of unexplained infertility, the female partners of the couples included in this study shared one common feature, low serum concentrations of progesterone (<10 ng/ml), on Day 21 of the last unsupplemented cycle (Table  2 ), in spite of the presence of apparently normal corpus luteum detected by ultrasound on the same cycle day. Serum progesterone concentration was determined by a solid phase, competitive immunoassay using enzymelabeled chemiluminescent technology (Immulite 1000 Progesterone, Siemens, Bellport, NY, USA).
The male partners were aged between 23 and 38 years, had normal sperm count, motility and morphology [10] , and none of them had pathologically increased levels of sperm DNA fragmentation [11] . Couples with endocrine or systemic disorders that increased the risk of infertility, such as diabetes and pre-diabetes, abnormalities of thyroid gland function, autoimmune diseases, genetic defects, smoking and drug abuse, detected in one or both partners, were excluded from the study.
After careful examination of all potential causes of infertility, the couples were counselled to have three consecutive attempts at natural conception with ovulationsynchronized timed sexual intercourse and subsequent luteal phase support with exogenous progesterone supplementation. The day of ovulation was determined by repeated vaginal ultrasound scans, carried out every other day beginning with the 7 th day of the menstrual cycle. The couples were advised to have frequent sexual intercourse when the dominant follicle had reached the size of 17 mm in diameter. The ultrasound examinations were continued to detect signs of ovulation. As soon as ovulation was confirmed, the patients were given 600 mg exogenous micronized progesterone (Utrogestan, Besins Healthcare, Monaco) daily by the vaginal route. This treatment was continued until the 28 th day of the cycle, when serum b-HCG concentration was determined to detect pregnancy. In case of the positive pregnancy test, serum progesterone concentration was repeated once a week, and progesterone supplementation was continued until normal and stable progesterone concentrations were achieved. This time did not exceed two additional weeks from the time of ovulation in any case. Ultrasound pregnancy diagnosis was undertaken 6-7 weeks after the last menstrual period.
Results and Discussion
As compared with the last unsupplemented cycle, serum concentrations of progesterone in the first supplemented cycle were within the normal range (>10 ng/ml) in all women involved in this study ( Table 2) . Six of them became pregnant after the timed sexual intercourse. One of these pregnancies was achieved in the first progesterone-supplemented cycle, one in the second one and four in the third ( Table 2 ). All pregnancies were singleton. One of the six pregnancies (Case 7) resulted in a miscarriage, and five normal babies were born.
These data suggest that LPD may be a cause of infertility in some couples in whom no other cause underlying fertility problems is identified either in the male or the female partner. This finding contradicts the opinion of the practice committee of the American Society for Reproductive Medicine, which concluded that LPD, as an independent entity causing infertility, has not been proven [5] . The prevalence of this type of infertility was not evaluated in this study, but it appears to be low because more than two years, and more than 200 patients examined (after the exclusion of other possible causes of infertility) were needed to assemble the study group.
A recent study failed to prove a relationship between luteal phase length and infertility over a 12-month observation period [12] . Interestingly, none of the women included in our study showed abnormally short cycle length (Table 1) , and an apparently normal corpus luteum was observed by vaginal ultrasound scan in all of them. These data suggest that the corpus luteum is formed after ovulation and persists for a usual time in women with LPD. However, for unknown reasons, its secretion of progesterone, though sufficient to maintain the secretary endometrium, is too low to enable the establishment and maintenance of pregnancy. Another possibility is that secretion of progesterone from the corpus luteum is normal, but the secreted progesterone is excessively eliminated from serum by some, yet unknown mechanism. Further study is needed to address these issues.
In spite of the fact that an isolated LPD as a sole cause of infertility appears to be rare, it has to be taken into consideration. If it occurs in couples with otherwise unexplained infertility, the recourse to assisted reproduction may be avoidable, and the timed sexual intercourse with subsequent exogenous progesterone supplementation may be sufficient. Direct stimulation of the patient's corpus luteum by prolonged administration of GnRH agonist was shown to be useful to boost corpus luteum function both in GnRH antagonist-triggered [13, 14] and HCG-triggered [15] ovarian stimulation cycles. The evaluation of the use of GnRH agonists to increase luteal-phase progesterone secretion in natural cycles of women with LPD, instead of direct exogenous progesterone administration, is an interesting challenge for future research.
Though rare as an isolated factor causing infertility, LPD can be masked by other associated factors compromising fertility, of both male and female origin. If it is not correctly diagnosed, it may contribute to assisted reproduction failures. In fact, the observation that some women have a tendency toward a dysfunctional luteal phase in stimulated cycles, regardless of the treatment used [16, 17] , can be explained by a masked intrinsic LPD upon which the more or less negative effects of different ovarian stimulation protocols are superimposed. It is thus important to evaluate midluteal phase serum concentrations of progesterone in all cases of infertility, irrespectively of its main cause, and to take the eventual presence of LPD in consideration as a pre-requisite for the choice of optimal ovarian stimulation protocol and luteal phase support. Low concentrations of pregnanediol-3-alpha-glucuronide in first morning urine samples taken during the luteal phase can also be used as a predictor of abnormal luteal phase [18] .
In conclusion, the luteal phase concentrations of progesterone may still be neglected as a cause of infertility. If this condition is associated with other causes, for which an assisted reproduction treatment is indicated, its recognition can assist with selecting the optimal treatment protocol and help avoid unnecessary pregnancy losses. Post-ovulatory supplementation with progesterone as a treatment for LPD should be considered before attempting more invasive and extensive assisted reproductive procedures.
